Download PDF
Fortschr Neurol Psychiatr 2010; 78(2): 81-89
DOI: 10.1055/s-0028-1109978
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Psychose und Sucht bei Jugendlichen und Jungerwachsenen
Teil 1: Prävalenz und Erklärungsmodelle

Dual Diagnosis Psychosis and Substance Use Disorders in Adolescents – Part 1K. Meister1 , M. Burlon1 , L. Rietschel1 , E. Gouzoulis-Mayfrank2 , T. Bock1 , M. Lambert1
  • 1Psychosen-Ersterkennungs- und Behandlungsprojekt (PEB), Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin, Universitätskrankenhaus Hamburg-Eppendorf (Direktor: Prof. Dr. D. Naber)
  • 2LVR-Klinik Köln und Klinik für Psychiatrie und Psychotherapie, Universitätsklinik Köln (Direktor: Prof. Dr. J. Klosterkötter)
Further Information

Publication History

Publication Date:
09 February 2010 (online)

Also available at
   Permissions and Reprints
Preview

Zusammenfassung

Epidemiologische Studien bei schizophrenen Patienten zeigen ein Lebenszeitrisiko von 20 – 50 % für eine komorbide Suchtstörung. Bei Patienten mit einer ersten Episode liegt die Prävalenz für eine komorbide Suchterkrankung zwischen 25 – 75 %, vor allem Cannabisgebrauch. Diese schwierig zu behandelnde Patientengruppe hat meist einen schlechteren Verlauf als schizophrene Patienten, die keine komorbide Suchtstörung aufweisen. Trotz zahlreicher Erklärungsmodelle, wie der Selbstmedikationshypothese, allgemeinen oder bidirektionalen Faktorenmodellen oder genetischer Vulnerabilität, kann keines umfassend die hohe Suchtkomorbidität bei schizophrenen Patienten erklären, wobei dies wichtig wäre, um diese Gruppe besser behandeln zu können. Da die Gruppe der Doppeldiagnosepatienten sehr heterogen ist, ist es möglich, dass verschiedene Erklärungsmodelle die Komorbidität in verschiedenen Subgruppen erklären könnten. Der vorliegende erste Teil der Übersichtsarbeit „Doppeldiagnose Psychose und Sucht mit Schwerpunkt bei Jungerwachsenen” befasst sich mit der Prävalenz und Erklärungsmodellen. Der zweite Teil gibt dann eine Übersicht zu Verlauf und psychosozialen Behandlungsmöglichkeiten.

Abstract

Epidemiological studies suggest that 20 % to 50 % of patients with schizophrenia have a lifetime comorbid substance use disorder (SUD). In first-episode psychosis this prevalence is even higher and varies between 20 % and 75 % with cannabis being the most widely used illicit drug. These difficult to treat patients usually have a worse prognosis as compared with non-substance abusing schizophrenic patients. Despite multiple theories proposed such as the self medication hypothesis, common or bidirectional factor models or genetic vulnerability, there is no consensus on the aetiology of increased rates of substance use in people with psychosis which is important to treat these patients. The dually diagnosed population is a heterogeneous group and it is likely that different models may explain comorbidity in different subgroups. The present review part one gives an overview on prevalence and explanation models for dual diagnosis psychosis and substance use with focus in adolescent and young adult populations, the second part reviews the clinical course for both disorders and current psychosocial treatment options.

Schlüsselwörter

Doppeldiagnose - Psychose - Sucht - Epidemiologie - Erklärungsmodelle

Key words

dual diagnosis - psychosis - substance abuse disorder - epidemiology - etiological theories

Literatur

  • 1 Buckley P F. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.  Journal of Clinical Psychiatry. 2006;  67 5-9
    Search in Google Scholar
  • 2 Drake R E. Dual diagnosis.  Psychiatry. 2007;  6 381-384
    Search in Google Scholar
  • 3 Tiet Q Q, Mausbach B. Treatments for patients with dual diagnosis: a review.  Alcoholism: Clinical and Experimental Research. 2007;  31 513-536
    Search in Google Scholar
  • 4 Weltgesundheitsorganisation .Internationale Klassifikation psychischer Störungen: ICD 10, Kapitel V (F); klinisch-diagnostische Leitlinien. Bern; Huber 2000 4th
    Search in Google Scholar
  • 5 American Psychiatric Association .Diagnostisches und Statistisches Manual Psychischer Störungen – Textrevision- DSM-IV-TR. Göttingen; Hogrefe 2003
    Search in Google Scholar
  • 6 Martin C S, Winters K C. Diagnosis and assessment of alcohol use disorders among adolescents.  Alcohol Health and Research World. 1998;  22 95-105
    Search in Google Scholar
  • 7 Chambers R A, Krystal J H, Self D W. A neurobiological basis for substance abuse comorbidity in schizophrenia.  Biological Psychiatry. 2001;  50 71-83
    Search in Google Scholar
  • 8 Lambert M, Conus P, Lubman D I. et al . The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.  Acta Psychiatrica Scandinavica. 2005;  112 141-148
    Search in Google Scholar
  • 9 Hickman M, Vickerman P, Macleod J. et al . Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.  Addiction. 2007;  102 597-606
    Search in Google Scholar
  • 10 Larsen T K, Melle I, Auestad B. et al . Substance abuse in first-episode non-affective psychosis.  Schizophrenia Research. 2006;  88 55-62
    Search in Google Scholar
  • 11 Ajdacic-Gross V, Lauber C, Warnke I. et al . Changing incidence of psychotic disorders among the young in Zurich.  Schizophrenia Research. 2007;  95 9-18
    Search in Google Scholar
  • 12 Verdoux H, Tournier M, Cougnard A. Impact of substance use on the onset and course of early psychosis.  Schizophrenia Research. 2005;  79 69-75
    Search in Google Scholar
  • 13 Rehm J, Room R, Brink W. et al . Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology.  European Neuropsychopharmacology. 2005;  15 389-397
    Search in Google Scholar
  • 14 Westermeyer J. Comorbid schizophrenia and substance abuse: a review of epidemiology and course.  American Journal on Addictions. 2006;  15 345 s-355
    Search in Google Scholar
  • 15 Pfeiffer-Gerschel T, Kipke I, Lang P. et al .Bericht 2008 des nationalen REITOX-Knotenpunkts an die EBDD. Deutschland: Neue Entwicklungen, Trends und Hintergrundinformationen zu Schwerpunktthemen. Drogensituation 2007 / 2008. München; DBDD 2008
    Search in Google Scholar
  • 16 Europäische Beobachtungsstelle für Drogen und Drogensucht (EBDD) .Jahresbericht 2008: Stand der Drogenproblematik in Europa. Luxemburg; Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften 2008: 1-111
    Search in Google Scholar
  • 17 Kraus L, Augustin R, Orth B. Illegale Drogen, Einstiegsalter und Trends. Ergebnisse des Epidemiologischen Suchtsurvey 2003.  Sucht. 2005;  51 19-28
    Search in Google Scholar
  • 18 Perkonigg A, Lieb R, Höfler M. et al . Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents.  Addiction. 1999;  94 1663-1678
    Search in Google Scholar
  • 19 Sydow von K, Lieb R, Pfister H. et al . The natural course of cannabis use, abuse and dependence over 4 years: a longitudinal community study of adolescents and young adults.  Drug and Alcohol Dependence. 2001;  64 347-361
    Search in Google Scholar
  • 20 Töppich J. Cannabiskonsum von Jugendlichen. In, Jugendkult Cannabis – Risiken und Hilfen. Berlin; Die Drogenbeauftragte der Bundesregierung 2005: 15-19
    Search in Google Scholar
  • 21 Bonnet U, Harries-Hedder K, Leweke F M. et al . AWMF-Leitlinie: Cannabis-bezogene Störungen.  Fortschr Neurol Psychiatr. 2004;  72 318-329
    Search in Google Scholar
  • 22 Thomasius R, Stolle M. Diagnostik und Behandlung psychischer Störungen durch Cannabiskonsum.  Psychiatrie und Psychotherapie up2date 2. 2008;  2 225-239
    Search in Google Scholar
  • 23 Sonntag D, Bauer C, Hellwich A K. Deutsche Suchthilfestatistik 2005 für ambulante Suchteinrichtungen.  Sucht. 2006;  52 7-43
    Search in Google Scholar
  • 24 Bundeszentrale für gesundheitliche Aufklärung (BZgA) .Cannabiskonsum der Jugendlichen und jungen Erwachsenen in Deutschland. Ergebnisse der Repräsentativbefragung der Bundeszentrale für gesundheitliche Aufklärung. Köln; BZgA 2007
    Search in Google Scholar
  • 25 Die Drogenbeauftragte der Bundesregierung .Drogen- und Suchtbericht Mai 2008. Berlin; 2008
    Search in Google Scholar
  • 26 Bundeszentrale für gesundheitliche Aufklärung (BZgA) .Alkoholkonsum der Jugendlichen in Deutschland 2004 – 2007. Ergebnisse der Repräsentativbefragung der Bundeszentrale für gesundheitliche Aufklärung. Köln; BZgA 2007
    Search in Google Scholar
  • 27 Rabinowitz J, Bromet E J, Lavelle J. et al . Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.  Psychological Medicine. 1998;  28 1411-1419
    Search in Google Scholar
  • 28 Green B, Young R, Kavanagh D J. Cannabis use and misuse prevalence among people with psychosis.  British Journal of Psychiatry. 2005;  187 306-313
    Search in Google Scholar
  • 29 Blanchard J J, Brown S A, Horan W P. et al . Substance use disorders in schizophrenia: review, integration, and a proposed model.  Clinical Psychology Review. 2000;  20 207-234
    Search in Google Scholar
  • 30 Kraemer H C, Wilson K A, Hayward C. Lifetime prevalence and pseudocomorbidity in psychiatric research.  Archives of General Psychiatry. 2006;  63 604-608
    Search in Google Scholar
  • 31 Regier D A, Farmer M E, Rae D S. et al . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.  Journal of the American Medical Association. 1990;  264 2511-2518
    Search in Google Scholar
  • 32 Jacobsen L K, Southwick S M, Kosten T R. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.  American Journal of Psychiatry. 2001;  158 1184-1190
    Search in Google Scholar
  • 33 Kalbag A S, Levin F R. Adult ADHD and substance abuse: diagnostic and treatment issues.  Substance Use & Misuse. 2005;  40 1955-1958
    Search in Google Scholar
  • 34 Duke P J, Pantelis C, McPhillips M A. Comorbid non-alcohol substance misuse among people with schizophrenia.  British Journal of Psychiatry. 2001;  179 509-513
    Search in Google Scholar
  • 35 Lammertink M, Löhrer F, Kaiser R. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.  Acta Psychiatrica Scandinavica. 2001;  104 361-366
    Search in Google Scholar
  • 36 Linszen D H, Dingemans P M, Lenior M E. Cannabis use and the course of recent onset schizophrenic disorders.  Archives of General Psychiatry. 1994;  51 273-279
    Search in Google Scholar
  • 37 Wade D, Harrigan S, Edwards J. et al . Course of substance misuse and daily tobacco use in first-episode psychosis.  Schizophrenia Research. 2006;  81 145-150
    Search in Google Scholar
  • 38 Kavanagh D J, Waghorn G, Jenner L. et al . Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.  Schizophrenia Research. 2004;  66 115-124
    Search in Google Scholar
  • 39 Wobrock T, Pajonk F G, D’Amelio R. et al . Schizophrenie und Sucht.  psychoneuro. 2005;  31 433-440
    Search in Google Scholar
  • 40 Gouzoulis-Mayfrank E. Doppeldiagnose Psychose und Sucht – Grundlagen und Therapie.  Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. 2008;  36 245-253
    Search in Google Scholar
  • 41 Gouzoulis-Mayfrank E. Komorbidität Psychose und Sucht: Grundlagen und Praxis. Steinkopff Verlag 2007
    Search in Google Scholar
  • 42 Tiet Q Q, Finney J W, Moos R H. Screening psychiatric patients for illicit drug use disorders and problems.  Clinical Psychology Review. 2008;  28 578-591
    Search in Google Scholar
  • 43 Drake R E, Wallach M A, McGovern M P. Future directions in preventing relapse to substance abuse among clients with severe mental illnesses.  Psychiatric Services. 2005;  56 1297-1302
    Search in Google Scholar
  • 44 Cutler D L, Bevilacqua J, McFarland B H. Four decades of community mental health: a symphony in four movements.  Community Mental Health Journal. 2003;  39 381-398
    Search in Google Scholar
  • 45 Drake R E, Green A I, Mueser K T. The history of community mental health treatment and rehabilitation for persons with severe mental illness.  Community Mental Health Journal. 2003;  39 427-440
    Search in Google Scholar
  • 46 Mueser K T, Drake R E, Wallach M A. Dual diagnosis: a review of etiological theories.  Addictive Behaviors. 1998;  23 717-734
    Search in Google Scholar
  • 47 Gregg D, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis.  Clinical Psychology Review. 2007;  27 494-510
    Search in Google Scholar
  • 48 Khantzian E J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications.  Harvard Review of Psychiatry. 1997;  4 231-244
    Search in Google Scholar
  • 49 Schneier F R, Siris S G. A review of psychoactive substance use and abuse in schizophrenia.  Journal of Nervous and Mental Disease. 1987;  175 641-652
    Search in Google Scholar
  • 50 Dixon L, Haas G H, Weiden P J. et al . Drug abuse in schizophrenic patients: clinical correlates and reasons for use.  American Journal of Psychiatry. 1991;  148 224-230
    Search in Google Scholar
  • 51 Pencer A, Addington J. Reasons for using substances in adolescents with and without psychosis.  Early Intervention in Psychiatry. 2008;  2 42-44
    Search in Google Scholar
  • 52 Addington J, Duchak V. Reasons for substance use in schizophrenia.  Acta Psychiatrica Scandinavica. 1997;  96 233-329
    Search in Google Scholar
  • 53 Spencer C, Castle D, Michie P T. Motivations that maintain substance use among individuals with psychotic disorders.  Schizophrenia Bulletin. 2002;  28 233-247
    Search in Google Scholar
  • 54 Cantwell R, Brewin J, Glazebrook C. et al . Prevalence of substance misuse in first-episode psychosis.  British Journal of Psychiatry. 1999;  174 150-153
    Search in Google Scholar
  • 55 Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia.  Biological Psychiatry. 1996;  40 1155-1163
    Search in Google Scholar
  • 56 Bersani G, Orlandi V, Kotzalidis G D. et al . Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.  European Archives of Psychiatry and Clinical Neuroscience. 2002;  252 86-92
    Search in Google Scholar
  • 57 Canton-Graae E, Nordstrom L G, McNeil T F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.  Schizophrenia Research. 2001;  48 69-82
    Search in Google Scholar
  • 58 Barnett J H, Werners U, Secher S M. et al . Substance use in a population-based clinic sample of people with first-episode psychosis.  British Journal of Psychiatry. 2007;  190 515-520
    Search in Google Scholar
  • 59 Drake R E, Wallach M A, Alverson H S. et al . Psychosocial aspects of substance abuse by clients with severe mental illness.  Journal of Nervous and Mental Disease. 2002;  190 100-106
    Search in Google Scholar
  • 60 Drake R E, Mueser K T. Co-occuring alcohol use disorder and schizophrenia.  Alcohol Research and Health. 2002;  26 99-102
    Search in Google Scholar
  • 61 Drake R E, Wallach M A. Moderate drinking among people with severe mental illness.  Hospital and Community Psychiatry. 1993;  44 780-782
    Search in Google Scholar
  • 62 Swofford C D, Kasckow J W, Scheller-Gilkey G. Substance use: a powerful predictor of relapse in schizophrenia.  Schizophrenia Research. 1996;  20 145-151
    Search in Google Scholar
  • 63 Gonzalez V M, Bradizza C M, Vincent P C. et al . Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis.  Addictive Behaviors. 2007;  32 477-490
    Search in Google Scholar
  • 64 Phillips P, Johnson S. How does drug and alcohol misuse develop among people with psychotic illness? A literature review.  Social Psychiatry and Psychiatric Epidemiology. 2001;  36 269-276
    Search in Google Scholar
  • 65 O’Daly O G, Guillin O, Tsapakis E. et al . Schizophrenia and substance abuse comorbidity: a role for dopamine sensitization?.  Journal of Dual Diagnosis. 2005;  1 11-40
    Search in Google Scholar
  • 66 Rounsaville B J. DSM-V research agenda: substance abuse/psychosis comorbidity.  Schizophrenia Bulletin. 2007;  33 947-952
    Search in Google Scholar
  • 67 Thornicroft G, Meadows G, Politi P. Is „cannabis psychosis” a distinct category?.  European Psychiatry. 1992;  7 277-282
    Search in Google Scholar
  • 68 Arendt M, Rosenberg R, Foldager L. et al . Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.  British Journal of Psychiatry. 2005;  187 510-515
    Search in Google Scholar
  • 69 Arendt M, Preben B M, Rosenberg R. et al . Familial predisposition for psychiatric disorder comparison of subjects treated for cannabis-induced psychosis and schizophrenia.  Archives of General Psychiatry. 2008;  65 1269-1274
    Search in Google Scholar
  • 70 Boydell J, Dean K, Dutta R. et al . A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: Implications for the concept of cannabis psychosis.  Schizophrenia Research. 2007;  93 203-210
    Search in Google Scholar
  • 71 Caton C L, Hasin D S, Shrout P E. et al . Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis.  British Journal of Psychiatry. 2007;  190 105-111
    Search in Google Scholar
  • 72 Caton C L, Drake R E, Hasin D S. Differences between early phase primary psychotic disorders with concurrent substance use and substance-induced psychosis.  Archives of General Psychiatry. 2005;  62 137-145
    Search in Google Scholar
  • 73 Leweke F M, Gerth C W, Klosterkotter J. Cannabis-associated psychosis: current status of research.  CNS Drugs. 2004;  18 895-910
    Search in Google Scholar
  • 74 Fergusson D M, Poulton R, Smith P F. et al . Cannabis and psychosis.  British Medical Journal. 2006;  332 172-175
    Search in Google Scholar
  • 75 Arseneault L, Cannon M, Witton J. et al . Causal association between cannabis and psychosis: examination of the evidence.  British Journal of Psychiatry. 2004;  184 110-117
    Search in Google Scholar
  • 76 Henquet C, Murray R, Linszen D. et al . The environment and schizophrenia: the role of cannabis use.  Schizophrenia Bulletin. 2005;  31 608-612
    Search in Google Scholar
  • 77 Henquet C, Di Forti M, Morrison P. et al . Gene-environment interplay between cannabis and psychosis.  Schizophrenia Bulletin. 2008;  34 1111-1121
    Search in Google Scholar
  • 78 Andreasson S, Allebeck P, Engstrom A. Cannabis and schizophrenia. A longitudinal study of swedish conscripts.  Lancet. 1987;  2 1483-1486
    Search in Google Scholar
  • 79 Zammit S, Allebeck P, Andreasson S. et al . Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.  British Medical Journal. 2002;  325 1199
    Search in Google Scholar
  • 80 Moore T, Zammit S, Lingford-Hughes A. et al . Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.  Lancet. 2007;  370 319-328
    Search in Google Scholar
  • 81 Webb E, Ashton C H, Kelly P. et al . Alcohol and drug use in UK university students.  Lancet. 1996;  348 922-925
    Search in Google Scholar
  • 82 Arseneault L, Cannon M, Poulton R. et al . Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.  British Medical Journal. 2002;  325 1212-1213
    Search in Google Scholar
  • 83 Lieb R, Isensee B, v. Sydow K. et al . The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update.  European Addiction Research. 2000;  6 170-182
    Search in Google Scholar
  • 84 DeWitt D J, Adlaf E M, Offord D R. et al . Age at first alcohol use: a risk factor for the development of alcohol disorders.  American Journal of Psychiatry. 2000;  157 745-750
    Search in Google Scholar
  • 85 Chen C Y, Brian M S, Anthony J C. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000 – 2001.  Drug and Alcohol Dependence. 2005;  79 11-22
    Search in Google Scholar
  • 86 Rabinowitz J, Levine S Z, Häfner H. A population based elaboration of the role of age of onset on the course of schizophrenia.  Schizophrenia Research. 2006;  88 96-101
    Search in Google Scholar
  • 87 Nimwegen van L, Haan de L, Beveren van N. et al . Adolescence, schizophrenia and drug abuse: a window of vulnerability.  Acta Psychiatrica Scandinavica. 2005;  11 1-9
    Search in Google Scholar
  • 88 Pistis M, Perra S, Pillolla G. et al . Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.  Biological Psychiatry. 2004;  56 86-94
    Search in Google Scholar
  • 89 Solowij N, Michie P T. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?.  Journal of Psychiatry and Neuroscience. 2007;  32 30-52
    Search in Google Scholar
  • 90 Stefanis N C, Delespaul P, Henquet C. et al . Early adolescent cannabis exposure and positive and negative dimensions of psychosis.  Addiction. 2004;  99 1333-1341
    Search in Google Scholar
  • 91 Konings M, Henquet C, Maharajh H D. et al . Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.  Acta Psychiatrica Scandinavica. 2008;  118 209-213
    Search in Google Scholar
  • 92 Barnes T, Mutsatsa S, Hutton S. et al . Comorbid substance use and age at onset of schizophrenia.  British Journal of Psychiatry. 2006;  188 237-242
    Search in Google Scholar
  • 93 Veen N D, Selten P J, Tweel van der I. et al . Cannabis use and age at onset of schizophrenia.  American Journal of Psychiatry. 2004;  161 501-506
    Search in Google Scholar
  • 94 Mastrigt van S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program.  Social Psychiatry and Psychiatric Epidemiology. 2004;  39 69-72
    Search in Google Scholar
  • 95 Buhler B, Hambrecht M, Loffler W. et al . Precipitation and determination of the onset and course of schizophrenia by substance abuse – a retrospective and prospective study of 232 population-based first illness episodes.  Schizophrenia Research. 2002;  54 243-251
    Search in Google Scholar
  • 96 Compton M T, Kelley M E, Ramsay C E. et al . Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients.  Am J Psychiatry. 2009;  166 1251-1257
    Search in Google Scholar
  • 97 Semple D M, McIntosh A M, Lawrie S M. Cannabis as a risk factor for psychosis: systematic review.  Journal of Psychopharmacology. 2005;  19 187-194
    Search in Google Scholar
  • 98 vanNimwegen L, Haan de L, Beveren van N. et al . Adolescence, schizophrenia and drug abuse: a window of vulnerability.  Acta Psychiatr Scand. 2005;  11 1-9
    Search in Google Scholar
  • 99 Williams H J, Owen M J, O’Donovan M C. Is COMT a susceptibility gene for schizophrenia?.  Schizophrenia Bulletin. 2007;  33 635-641
    Search in Google Scholar
  • 100 Collaborative Working Group on Clinical Trial Evaluations . Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders.  Journal of Clinical Psychiatry. 1998;  59 41-45
    Search in Google Scholar
  • 101 Zammit S, Spurlock G, Williams H. et al . Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.  British Journal of Psychiatry. 2007;  191 402-407
    Search in Google Scholar
  • 102 Winkel van R, Hert de M, Vriendt de N. et al . No comfirmation of gene-environment interaction between COMT VAL158 MET and adolescent-onset cannabis use in large sample of patients with schizophrenia.  Schizophrenia Research. 2008;  98 78-79
    Search in Google Scholar
  • 103 Kirkbride J, Fearon P, Morgan C. et al . Heterogenity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study.  Archives of General Psychiatry. 2006;  63 250-258
    Search in Google Scholar
  • 104 Boydell J, Os O J, Caspi van A. et al . Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.  Psychological Medicine. 2006;  36 1441-1446
    Search in Google Scholar
  • 105 Os van J, Rutten B P, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.  Schizophrenia Bulletin. 2008;  34 1066-1082
    Search in Google Scholar
  • 106 Winkel van R, Stefanis N C, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.  Schizophrenia Bulletin. 2008;  34 1095-1105
    Search in Google Scholar
  • 107 Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis.  Drug and Alcohol Dependence. 2003;  71 37-48
    Search in Google Scholar
  • 108 Mueser K T, Crocker A G, Frisman L B. et al . Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.  Schizophrenia Bulletin. 2006;  32 626-636
    Search in Google Scholar
  • 109 Mueser K T, Yarnold P R, Rosenberg S D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups.  Schizophrenia Bulletin. 2000;  26 179-192
    Search in Google Scholar
  • 110 Hides L, Dawe S, Kavanagh D J. et al . Psychotic symptom and cannabis relapse in recent-onset psychosis.  British Journal of Psychiatry. 2006;  189 137-143
    Search in Google Scholar
  • 111 Ferdinand R F, Sondeijker F, Ende van der J. et al . Cannabis use predicts future psychotic symptoms, and vice versa.  Addiction. 2005;  100 612-618
    Search in Google Scholar

PD Dr. Martin Lambert

Psychosen-Ersterkennungs- und Behandlungsprojekt (PEB)
Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin
Universitätsklinikum Hamburg-Eppendorf

Martinistr. 52

20246 Hamburg

Email: lambert@uke.de